← Every company
AstraZeneca PLC SEC Filings
What AstraZeneca PLC has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.
AZN overview →Filings on file
28
since Mar 7, 2017
Warning signs
0
none filed
Last results
—
8-K item 2.02
Industry
Pharmaceutical Preparations
SIC 2834
Newest first
Each label is a form type or an 8-K item as filed; each row links to the filing.
| Filed | What it reports | Document |
|---|---|---|
| May 28, 2026 | Delisting 25-NSE | Read ↗ |
| Apr 8, 2026 | Delisting 25-NSE | Read ↗ |
| Feb 24, 2026 | Annual report 20-F | Read ↗ |
| Jan 30, 2026 | Delisting 25 | Read ↗ |
| Nov 14, 2025 | Delisting 25-NSE | Read ↗ |
| Feb 18, 2025 | Annual report 20-F | Read ↗ |
| Jun 4, 2024 | Delisting 25-NSE | Read ↗ |
| Feb 20, 2024 | Annual report 20-F | Read ↗ |
| Dec 27, 2023 | Tender offer SC TO-T | Read ↗ |
| Nov 14, 2023 | Delisting 25-NSE | Read ↗ |
| Aug 16, 2023 | Delisting 25-NSE | Read ↗ |
| May 25, 2023 | Delisting 25-NSE | Read ↗ |
| Feb 21, 2023 | Annual report 20-F | Read ↗ |
| Jan 23, 2023 | Tender offer SC TO-T | Read ↗ |
| Jun 10, 2022 | Delisting 25-NSE | Read ↗ |
| Jun 9, 2022 | Delisting 25-NSE | Read ↗ |
| Feb 22, 2022 | Annual report 20-F | Read ↗ |
| Feb 16, 2021 | Annual report 20-F | Read ↗ |
| Nov 13, 2020 | Delisting 25-NSE | Read ↗ |
| Sep 24, 2020 | Delisting 25 | Read ↗ |
| Mar 3, 2020 | Annual report 20-F | Read ↗ |
| Sep 18, 2019 | Delisting 25-NSE | Read ↗ |
| Mar 5, 2019 | Annual report 20-F | Read ↗ |
| Nov 16, 2018 | Delisting 25-NSE | Read ↗ |
| Nov 16, 2018 | Delisting 25-NSE | Read ↗ |
| Mar 6, 2018 | Annual report 20-F | Read ↗ |
| Sep 15, 2017 | Delisting 25-NSE | Read ↗ |
| Mar 7, 2017 | Annual report 20-F | Read ↗ |
Source: AstraZeneca PLC's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.
More on AZN
Company overviewEverything on AZN in one place, with the price.Insider tradingWhat AZN's own officers and directors buy and sell.LobbyingWhat AZN spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on AZN's account, and who they worked for.Federal contractsWhat federal agencies pay AZN.PatentsWhat AZN is filing at the patent office.Workplace safetyWhat OSHA found at AZN's sites.